- ABBV has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $378.1 million.
- ABBV traded 16,776 shares today in the pre-market hours as of 9:30 AM.
- ABBV is down 2% today from yesterday's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ABBV with the Ticky from Trade-Ideas. See the FREE profile for ABBV NOW at Trade-Ideas More details on ABBV: AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The stock currently has a dividend yield of 2.8%. ABBV has a PE ratio of 30.2. Currently there are 7 analysts that rate AbbVie a buy, no analysts rate it a sell, and 3 rate it a hold. The average volume for AbbVie has been 12.8 million shares per day over the past 30 days. AbbVie has a market cap of $110.6 billion and is part of the health care sector and drugs industry. Shares are up 30.9% year-to-date as of the close of trading on Tuesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. TheStreetRatings.com Analysis: TheStreet Quant Ratings rates AbbVie as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income.